263 related articles for article (PubMed ID: 31793638)
1. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
[TBL] [Abstract][Full Text] [Related]
3. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
4. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.
Kamar N; Lhomme S; Abravanel F; Cointault O; Esposito L; Cardeau-Desangles I; Del Bello A; Dörr G; Lavayssière L; Nogier MB; Guitard J; Ribes D; Goin AL; Broué P; Metsu D; Sauné K; Rostaing L; Izopet J
Transplantation; 2015 Oct; 99(10):2124-31. PubMed ID: 26214817
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
[TBL] [Abstract][Full Text] [Related]
6. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis E virus.
Dalton HR; Kamar N
Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy in chronic hepatitis E: a systematic review.
Peters van Ton AM; Gevers TJ; Drenth JP
J Viral Hepat; 2015 Dec; 22(12):965-73. PubMed ID: 25760481
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
11. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
12. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.
Del Bello A; Abravanel F; Alric L; Lavayssiere L; Lhomme S; Bellière J; Izopet J; Kamar N
Transpl Infect Dis; 2019 Aug; 21(4):e13093. PubMed ID: 30972874
[TBL] [Abstract][Full Text] [Related]
13. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients.
Marion O; Abravanel F; Del Bello A; Esposito L; Lhomme S; Puissant-Lubrano B; Alric L; Faguer S; Izopet J; Kamar N
Liver Int; 2018 Dec; 38(12):2178-2189. PubMed ID: 29845733
[TBL] [Abstract][Full Text] [Related]
15. Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.
Lhomme S; Kamar N; Nicot F; Ducos J; Bismuth M; Garrigue V; Petitjean-Lecherbonnier J; Ollivier I; Alessandri-Gradt E; Goria O; Barth H; Perrin P; Saune K; Dubois M; Carcenac R; Lefebvre C; Jeanne N; Abravanel F; Izopet J
Antimicrob Agents Chemother; 2015 Dec; 60(3):1608-14. PubMed ID: 26711757
[TBL] [Abstract][Full Text] [Related]
16. Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis.
Kamar N; Lhomme S; Abravanel F; Marion O; Peron JM; Alric L; Izopet J
Viruses; 2016 Aug; 8(8):. PubMed ID: 27537905
[TBL] [Abstract][Full Text] [Related]
17. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
18. Practical considerations when treating chronic hepatitis E in solid organ transplant recipients.
Choi DK; Martin MT; Chacra W; Chan C; Koppe S; Landers L; Naveed A; Mikolajczyk AE
Int J Clin Pharm; 2021 Jun; 43(3):753-755. PubMed ID: 33169803
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
[TBL] [Abstract][Full Text] [Related]
20. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.
De Winter BCM; Hesselink DA; Kamar N
Pharmacol Res; 2018 Apr; 130():308-315. PubMed ID: 29499270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
